Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Nov 30, 2024 | (Q2)May 31, 2024 | (Q1)Feb 29, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | (Q3)Aug 31, 2023 | (Q2)May 31, 2023 | (Q1)Feb 28, 2023 | (FY)Nov 30, 2022 | (Q4)Nov 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.25%18.23B | 30.50%5.17B | 10.69%4.06B | 9.27%17.83B | 7.89%5.04B | 38.80%5.16B | -17.58%3.96B | 17.53%3.67B | 17.74%16.32B | 10.80%4.67B |
| Cost of revenue | 2.31%15.03B | 36.29%4.3B | 10.47%3.27B | 15.15%14.69B | 14.30%4.39B | 47.64%4.19B | -14.69%3.16B | 24.21%2.96B | 22.97%12.76B | 16.93%3.84B |
| Gross profit | 1.96%3.21B | 7.81%867.86M | 11.56%798.18M | -11.80%3.14B | -21.59%654.98M | 10.26%968.39M | -27.26%805M | -3.84%715.45M | 2.17%3.56B | -10.69%835.3M |
| Operating expense | -1.93%3.35B | 3.29%858.79M | 5.19%816.94M | 9.49%3.42B | -0.32%909.59M | 15.82%902.13M | 14.50%831.43M | 10.02%776.65M | 8.44%3.12B | 18.98%912.49M |
| Operating profit | 46.26%-148.32M | 134.34%9.08M | 69.34%-18.76M | -162.61%-275.98M | -229.85%-254.61M | -33.34%66.26M | -106.95%-26.43M | -260.52%-61.2M | -27.51%440.8M | -145.84%-77.19M |
| Net non-operating interest income (expenses) | -76.94%-130.9M | -25.35%-24.64M | -63.18%-30.02M | -11.05%-73.98M | 28.75%-13.8M | -38.29%-22.13M | -17.01%-19.65M | -27.34%-18.4M | -79.12%-66.61M | -63.92%-19.37M |
| Non-operating interest income | 42.72%18.82M | 735.86%14.43M | 332.87%10.34M | 117.57%13.19M | 135.45%4.66M | 156.75%4.41M | 46.02%1.73M | 102.20%2.39M | 41.25%6.06M | -20.03%1.98M |
| Non-operating interest expense | 71.76%149.72M | 82.71%39.06M | 94.17%40.35M | 19.94%87.16M | -13.52%18.47M | 49.78%26.54M | 18.92%21.38M | 32.99%20.78M | 75.20%72.68M | 49.38%21.35M |
| Net investment income | -68.63%22.38M | -258.95%-4.65M | 76.75%15.65M | 8,663.76%71.34M | 851.83%36.07M | 204.47%23.48M | -73.50%2.93M | 167.32%8.85M | -86.76%814K | -140.99%-4.8M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 169.85M | 0 | ||||||||
| Income from associates and other participating interests | 83.44%-116.46M | -108.52%-2.28M | -74.17%4.41M | -759.81%-703.29M | -2,646.71%-757.93M | -53.15%10.81M | -17.34%26.75M | -20.17%17.09M | 13.25%106.59M | 81.57%29.76M |
| Special income (charges) | -45.48%-131.2M | 631.61%14.74M | 329.93%19.08M | -536.26%-90.18M | -943.22%-80.87M | -615.14%-3.03M | -72.34%2.02M | -358.60%-8.3M | -34.48%20.67M | 476.86%9.59M |
| Less:Restructuring and mergern&acquisition | --665.39M | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Other special charges | -19,843.21%-599.49M | -631.61%-14.74M | -329.93%-19.08M | 86.11%-3.01M | -28.41%-12.32M | 615.14%3.03M | 72.34%-2.02M | 298.94%8.3M | 31.43%-21.63M | -476.86%-9.59M |
| Less:Write off | -29.93%65.3M | ---- | ---- | 9,587.01%93.19M | --93.19M | ---- | ---- | ---- | --962K | --0 |
| Other non-operating income (expenses) | 1,464.67%93.05M | 2,681.74%28.27M | -1,708.45%-4.57M | 207.89%5.95M | -218.74%-10.3M | 89.76%17.06M | 95.13%-1.1M | 142.07%284K | 67.17%-5.51M | 368.06%8.68M |
| Income before tax | 77.34%-241.6M | 232.45%20.52M | 76.95%-14.21M | -314.62%-1.07B | -1,927.68%-1.08B | -25.29%92.46M | -103.95%-15.49M | -278.92%-61.67M | -22.66%496.75M | -139.43%-53.33M |
| Income tax | 251.41%182M | 350.73%91.01M | 66.26%65M | -62.56%51.79M | -45.45%-66.33M | 176.21%58.84M | -85.63%20.19M | 76.67%39.1M | -25.25%138.33M | -284.55%-45.61M |
| Net income | 62.11%-423.61M | -97.54%-70.49M | 21.39%-79.21M | -411.91%-1.12B | -13,035.49%-1.02B | -67.19%33.62M | -114.20%-35.68M | -916.69%-100.76M | -21.61%358.42M | -106.99%-7.73M |
| Net income continuous operations | 62.11%-423.61M | -97.55%-70.49M | 21.39%-79.21M | -411.91%-1.12B | -13,033.78%-1.02B | -67.19%33.62M | -114.20%-35.68M | -916.69%-100.76M | -21.61%358.42M | -106.99%-7.73M |
| Noncontrolling interests | -253.74%-324.79M | -7,473.40%-41.59M | -161.81%-36.28M | -106.93%-91.82M | -450.19%-63.21M | -369.45%-15.32M | 103.16%564K | -17.52%-13.86M | 47.66%-44.37M | 62.02%-11.49M |
| Net income attributable to the company | 90.37%-98.82M | 20.26%-28.9M | 50.59%-42.94M | -354.76%-1.03B | -25,416.65%-951.91M | -53.71%48.94M | -113.47%-36.25M | -460.19%-86.91M | -25.69%402.79M | -97.33%3.76M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 90.37%-98.82M | 20.26%-28.9M | 50.59%-42.94M | -354.76%-1.03B | -25,416.65%-951.91M | -53.71%48.94M | -113.47%-36.25M | -460.19%-86.91M | -25.69%402.79M | -97.33%3.76M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 90.38%-7.18 | 20.15%-2.1 | 50.71%-3.12 | -364.35%-74.6 | -11,261.29%-69.2 | -52.72%3.56 | -114.27%-2.63 | -485.98%-6.33 | -21.52%28.22 | -93.45%0.62 |
| Diluted earnings per share | 90.38%-7.18 | 20.50%-2.1 | 50.71%-3.12 | -364.35%-74.6 | -25,354.37%-69.2 | -52.72%3.56 | -114.33%-2.6414 | -485.98%-6.33 | -21.52%28.22 | -97.11%0.274 |
| Dividend per share | 0.00%7 | 0 | 0 | -30.00%7 | -30.00%7 | 0 | 0 | 0 | 233.33%10 | 233.33%10 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |